Nagendran Sukumar bought TSHA
November 28, 2025 · Form 4 insider transaction
Nagendran Sukumar bought 70,172 shares of Taysha Gene Therapies, Inc. at $0.70 per share, a transaction worth $49.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
70,172
Price
$0.70
Total value
$49.0K
InsiderNagendran Sukumar
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 28, 2025
Filing dateDecember 1, 2025
Shares owned after1,076,611
OwnershipDirect
10b5-1 planNo
AmendedNo